In a powerful response to a tragic surge in violence, Quavo and his nonprofit, The Rocket Foundation, have launched an Emergency Therapy Support Fund aimed at helping families impacted by a recent ...

A patient who received an experimental gene therapy developed by Rocket Pharmaceuticals has died following treatment, the company disclosed Tuesday. According to Rocket, the patient experienced what’s ...

A Rocket Pharmaceuticals gene therapy has reached the end of its regulatory journey before receiving an FDA decision. The company has withdrawn the submission for its therapeutic candidate for Fanconi ...

The FDA has slapped a clinical hold on Rocket Pharmaceuticals’ pivotal gene therapy trial in response to a death. Rocket, which was aiming to report data in mid-2026, dropped its targeted trial ...

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), a firm focused on developing cardiovascular gene therapy, announced a strategic corporate reorganization to extend its runway. The restructuring and ...

Rocket Pharmaceuticals has shared early data from three patients that tie its gene therapy for an inherited heart disease to a well-tolerated safety profile, which has been heralded by analysts as ...